Patents by Inventor Craig Baysinger

Craig Baysinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10188862
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: January 29, 2019
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
  • Publication number: 20160375247
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Application
    Filed: September 6, 2016
    Publication date: December 29, 2016
    Inventors: Brett WINGEIER, Barbara GIBB, Craig BAYSINGER, Thomas TCHENG, Suresh GURUNATHAN
  • Patent number: 9463322
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: October 11, 2016
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
  • Patent number: 9421380
    Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: August 23, 2016
    Assignee: NeuroPace, Inc.
    Inventors: Brett D Wingeier, Suresh Gurunathan, Craig Baysinger
  • Publication number: 20160235991
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Application
    Filed: April 21, 2016
    Publication date: August 18, 2016
    Inventors: Brett WINGEIER, Barbara GIBB, Craig BAYSINGER, Thomas TCHENG, Suresh GURUNATHAN
  • Patent number: 9345884
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: May 24, 2016
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
  • Publication number: 20150297896
    Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.
    Type: Application
    Filed: July 1, 2015
    Publication date: October 22, 2015
    Inventors: Brett D. WINGEIER, Suresh GURUNATHAN, Craig BAYSINGER
  • Patent number: 9101771
    Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 11, 2015
    Assignee: NeuroPace, Inc.
    Inventors: Brett D Wingeier, Suresh Gurunathan, Craig Baysinger
  • Publication number: 20140277289
    Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: NeuroPace, Inc.
    Inventors: Brett D. WINGEIER, Suresh GURUNATHAN, Craig BAYSINGER
  • Publication number: 20140094876
    Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.
    Type: Application
    Filed: September 28, 2012
    Publication date: April 3, 2014
    Applicant: NeuroPace, Inc.
    Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
  • Publication number: 20030004428
    Abstract: A system and method for detecting and predicting neurological events with an implantable device uses a relatively low-power central processing unit in connection with signal processing circuitry to identify features (including half waves) and calculate window-based characteristics (including line lengths and areas under the curve of the waveform) in an electrographic signal received from a patient's brain. The features and window-based characteristics are combinable in various ways according to the invention to detect and predict neurological events in real time, enabling responsive action by the implantable device.
    Type: Application
    Filed: June 28, 2001
    Publication date: January 2, 2003
    Inventors: Benjamin D. Pless, Stephen T. Archer, Craig Baysinger, Barbara Gibb, Suresh K. Gurunathan, Bruce Kirkpatrick, Thomas K. Tcheng